Filing Flows › Neogenomics (NEO) › Free cash flow
Neogenomics (NEO) free cash flow by quarter
Neogenomics' free cash flow was $11.7M in Q2 2026 (second quarter 2026), up 21-fold from Q3 2025. Over the last 3 quarters it ranged from $570K (Q3 2025) to $14.0M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $11.7M | 21× | -16% |
| Q3 2025 | $570K | -96% | — |
| Q2 2025 | $14.0M | — | — |
Q2 2026 at a glance
Neogenomics, Q2 2026: revenue $202M (+11% year over year), operating margin -4.8%, net earnings $2.2M, operating cash flow $20.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Neogenomics' free cash flow?
Neogenomics' free cash flow was $11.7M in Q2 2026 (second quarter 2026), up 21-fold from Q3 2025.
How has Neogenomics' free cash flow changed?
Over the last 3 quarters it ranged from $570K (Q3 2025) to $14.0M (Q2 2025).